WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 55'2901 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 76'3051 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 4'762  4'726  4'700  4'686  4'682  3'849  3'569  3'435 
Births 66  67  69  70  71  58  51  72 
Surviving infants 65  67  68  70  71  57  51  71 
Pop. less than 5 years 338  344  353  358  364  269  280  361 
Pop. less than 15 years 1'030  1'026  1'022  1'012  1'004  823  982  1'045 
Female 15-49 years 1'128  1'128  1'131  1'143  1'159  1'022  883  786 

Number of reported cases

(Click for retrospective incidence data for Ireland)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  25  33  51  556  1'106 
Mumps
ChartChart
  318  2'016  762  228 
Pertussis
ChartChart
  264  118  73  175  803  547 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ireland)
Vaccine year result method % card seen                                                
BCG          20  86  87  86 
DTP1         
DTP3          95  95  95  96  96  86  65  34 
DTP4         
IPV1         
HepB_BD         
HepB3          95  95  95  95  95 
Hib3          95  95  95  96  95  85 
JapEnc         
MCV1          92  92  93  93  92  79 
MCV2         
MenA         
PCV1         
PCV2         
PCV3          91  91  92  92  91 
Pol3          95  95  95  96  96  86  81  72 
Rota1         
RotaC         
RCV1          92  92  93  93  92 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ireland)
BCG
ChartChart
  18  77  74  76  89  84 
DTP1
ChartChart
  98  98  98  98  98  95  85  59 
DTP3
ChartChart
  95  95  95  96  96  86  65  34 
HepB3
ChartChart
  95  95  95  95  95 
HepB_BD
 
Hib3
ChartChart
  95  95  95  96  95  85 
MCV1
ChartChart
  92  92  93  93  92  79  78 
MCV2
 
PCV3
ChartChart
  91  91  92  92  91 
Pol3
  95  95  95  96  96  86  81  72 
RCV1
ChartChart
  92  92  93  93  92  79  78 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 32  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 94
From 80 to 89% 3
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
3
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; No risk groups
DTaPHibHepBIPV 2, 4, 6 months; Yes
HepB_Adult 1st contact; +1, +5 months; Yes risk groups
HepB_Pediatric 1st contact, +1, +5 months; Yes risk groups
HIB 13 months; Yes and defined risk groups
HPV 12-13 years; +5 months; Yes females in 1st year of second level schools or equivilant age, MSM and HIV-positive up to 26 years
Influenza_Adult >=65 years; Yes and adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilitities, Haj or other travellers, other risk groups
Influenza_Pediatric Yes children with chronic illness
MenB 2, 4, 12 months; Yes
MenC_conj 6, 13 months; 12-13 years; Yes
MMR 12 months; 4-5 years; Yes and HCWs, during outbreaks, individuals born before 1978, and other risk groups
Pneumo_conj 2, 6, 12 months; Yes
Pneumo_ps >=65 years; Yes and children >=2 years at risk;
Rotavirus 2, 4 months; Yes
Tdap 12-13 years; Yes defined risk groups and every 10 years
TdaPIPV 4-5 years; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes    Yes  No  Yes    Yes 
What years does the MYP cover? number 2016-2017    2015-2016    2013-2014    2011 -2012 
Nº of districts with microplans that include activities to raise immunization coverage number 32    32         

System performance

Total Nº districts in country number 32   
Nº districts with DTP3 coverage >=80% number 31 
% of districts with DTP3 coverage >=80% From 0 to 100% 97    100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 19    25  25  38  25  13 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes    Yes    Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  Yes    Yes    Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100    95    90    90 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.